Bacteriophobic Coatings for Inhibition of Pathogenic Biofilms
Bacteriophobic Coatings for Inhibition of Pathogenic Biofilms
批准号:
7461115
负责人:
MARK W. GRINSTAFF
金额:
$41.59万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2012-03-31
关键词:
AddressAdsorptionAffectAffinityAftercareAmino AcidsAnimalsAntibiotic ResistanceAntibiotic TherapyAntibioticsAppearanceAreaBacteriaBacterial AdhesionBacterial InfectionsBindingBiologicalBiologyBiomedical EngineeringBiotinC-reactive proteinCartoonsCell AdhesionCell membraneCell-Matrix JunctionCellsChemical EngineeringChemistryClassificationClinicClinicalConditionCountCoupledCouplingCovalent InteractionDebridementDevelopmentDevicesEngineeringEnzyme-Linked Immunosorbent AssayEvaluationExcisionExhibitsExternal Fixation DevicesFailureFibronectinsFocus GroupsFractureFutureGlassGoalsGoldGrowthHandHealthHealth Care CostsHip region structureHistologyHourImageImplantIn VitroInfectionInvestigationIonic StrengthsKnee ProsthesisLegLengthLibrariesMeasuresMedicalMedical DeviceMembraneMetalsMicrobial BiofilmsModelingMonitorMorbidity - disease rateMorphologyOperative Surgical ProceduresOrthopedicsOryctolagus cuniculusOutcomePatientsPeptide LibraryPeptide SynthesisPeptidesPerformancePerioperativePhage DisplayPhasePlayPolyethylene GlycolsPreparationProceduresProtein InhibitionProteinsPublic HealthQuartzRangeRateResearchRoleScanning Electron MicroscopyScreening procedureSerumSilverSimulateSiteSolidSolutionsSpecificityStainless SteelStandards of Weights and MeasuresStaphylococcus aureusSurfaceSurgical complicationSystemTechnologyTemperatureTestingTiAl6V4Tibial FracturesTimeTissuesTitaniumVariantWhite Blood Cell Count procedureWhole BloodWorkbaseboneclinically significantcompare effectivenessdesignengineering designfluid flowimplant materialimplantable deviceimplantationimprovedin vivoinhibitor/antagonistinnovationinterdisciplinary approachloss of functionmagaininmedical implantnovel strategiespathogenphysical propertypreventprotein aminoacid sequenceresearch studyretinal rodssuccesssurface coatingtibia
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Bacteriophobic Coatings for Inhibition of Pathogenic Biofilms
This proposal describes the preparation, characterization, and evaluation of functional coatings for the inhibition of bacterial cell colonization and biofilm formation on orthopaedic implants. Bacterial infections are the second most commonly attributed cause of implant failure. Such infections, which become established on plates, rods, screws and pins, necessitate prolonged antibiotic treatment and/or removal of the implant with multiple washout/debridement procedures to eradicate the infection, followed by implantation of a new device. This treatment is associated with high patient morbidity, loss of function, and significant health care costs. To address this need, bacteria repellant coatings are proposed that function as a physical barrier to bacterial cell attachment or as bioactive moieties to disrupt the bacterial membrane. A prototypical coating that inhibits bacteria colonization has been designed, synthesized, and evaluated. A detailed, systematic investigation is proposed that encompasses the following specific aims for this four-year proposal:
Aim 1. Identify peptides that bind to titanium using phage display and measure the binding affinity and selectivity of these peptides to titanium. Aim 2. Synthesize and characterize functional multivalent bacteriophobic coatings. Aim 3. Characterize biofilm inhibition in vitro and ex vivo on titanium with and without the bacteriophobic coating. Aim 4. Demonstrate reduction of perioperative infection rates in vivo.
The results of successful completion of this study will be: 1) identification of one or more bacteriophobic coatings; 2) understanding of the advantages and limitations of this strategy to reduce the rate of implant infection; 3) identification of potential design variations for improved performance; 4) demonstration of a new approach that may lessen the use of antibiotics and the resulting clinical challenges associate with treating antibiotic resistant pathogens; and 5) contributions to the design and engineering of future bacteriophobic coatings that possess specific physical properties or biological activities for a variety of implant metals.
PUBLIC HEALTH RELEVANCE The current treatment for implant-associated infections includes prolonged antibiotic treatment and/or replacement of the infected implant. This treatment is less than ideal, and innovative strategies to prevent bacterial colonization on medical devices are needed. This proposal addresses this national health need through development and evaluation of new coatings that prevent implant associated infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
R21: A novel antibody-drug conjugate for treatment of squamous cell lung carcinoma
-
批准号:10510002
-
项目类别:
-
资助金额:$19.28万
-
财政年份:2022
-
负责人:MARK W. GRINSTAFF
-
依托单位:
R21: A novel antibody-drug conjugate for treatment of squamous cell lung carcinoma
-
批准号:10671669
-
项目类别:
-
资助金额:$22.68万
-
财政年份:2022
-
负责人:MARK W. GRINSTAFF
-
依托单位:
The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation
-
批准号:10708018
-
项目类别:
-
资助金额:$65.28万
-
财政年份:2022
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder
-
批准号:10443323
-
项目类别:
-
资助金额:$62.14万
-
财政年份:2022
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder
-
批准号:10669219
-
项目类别:
-
资助金额:$62.53万
-
财政年份:2022
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Translational Research in Biomaterials
-
批准号:10259674
-
项目类别:
-
资助金额:$19.97万
-
财政年份:2020
-
负责人:MARK W. GRINSTAFF
-
依托单位:
A novel approach for reversal of autophagic defects using lysosome-targeted nanoparticles
-
批准号:9914192
-
项目类别:
-
资助金额:$20.06万
-
财政年份:2019
-
负责人:MARK W. GRINSTAFF
-
依托单位:
A novel approach for reversal of autophagic defects using lysosome-targeted nanoparticles
-
批准号:9752911
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2019
-
负责人:MARK W. GRINSTAFF
-
依托单位:
R21: Acidic Nanoparticles for Restoration of Autophagy in Age-associated NAFLD
-
批准号:9902306
-
项目类别:
-
资助金额:$20.06万
-
财政年份:2019
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Dissolvable Hydrogel Dressing for the Treatment of Burns
-
批准号:9010534
-
项目类别:
-
资助金额:$39.18万
-
财政年份:2016
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Synthesis, Characterization, and Evaluation of Polymeric Tissue Lubricants
-
批准号:8886944
-
项目类别:
-
资助金额:$36.47万
-
财政年份:2014
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Synthesis, Characterization, and Evaluation of Polymeric Tissue Lubricants
-
批准号:9303267
-
项目类别:
-
资助金额:$36.92万
-
财政年份:2014
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Synthesis, Characterization, and Evaluation of Polymeric Tissue Lubricants
-
批准号:9096649
-
项目类别:
-
资助金额:$36.72万
-
财政年份:2014
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Tunable Nanofiber Mesh Coatings for Improved Nanopores Sensing
-
批准号:8569026
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2013
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Tunable Nanofiber Mesh Coatings for Improved Nanopores Sensing
-
批准号:8695348
-
项目类别:
-
资助金额:$19.85万
-
财政年份:2013
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Characterizing electrostatic interactions between glycosaminoglycans and cationic
-
批准号:8297793
-
项目类别:
-
资助金额:$26.98万
-
财政年份:2012
-
负责人:MARK W. GRINSTAFF
-
依托单位:
A Portable Wound Hemostasis System Using a Hydrogel Polymeric Foam
-
批准号:8512721
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2012
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Characterizing electrostatic interactions between glycosaminoglycans and cationic
-
批准号:8607191
-
项目类别:
-
资助金额:$28.68万
-
财政年份:2012
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Characterizing electrostatic interactions between glycosaminoglycans and cationic
-
批准号:8438410
-
项目类别:
-
资助金额:$30.01万
-
财政年份:2012
-
负责人:MARK W. GRINSTAFF
-
依托单位:
Characterizing electrostatic interactions between glycosaminoglycans and cationic
-
批准号:8824946
-
项目类别:
-
资助金额:$27.43万
-
财政年份:2012
-
负责人:MARK W. GRINSTAFF
-
依托单位:
海外基金